xRead - September 2022

Wise et al.

Page 169

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Nothing to disclose

Author

Company

Nature of relationship

OptiNose

Advisory board

Sandra Y. Lin, MD

Agency for Healthcare Research and Quality

Research funding

Elina Toskala, MD, PhD, MBA

Medtronic

Research funding

Richard R. Orlandi, MD

Medtronic

Consultant

BioInspire

Consultant

480 Biomedical

Consultant

Cezmi A. Akdis, MD

Davos Diagnostics

Company shares

Allergopharma

Research funding

Actellion AG

Research funding

Jeremiah A. Alt, MD, PhD

University of Utah Program in Personalized Heath and the National Center for Advancing Translational Sciences of the NIH National Institute of Allergy and Infectious Diseases National Institute of Deafness and Other Communication Disorders

Research funding

Research funding

Research funding

Medtronic

Consultant

GlycoMira Therapeutics

Consultant

Spirox

Consultant

AngioSonic

Consultant

Antoine Azar, MD

Relez Therapeutics

Research funding

Shire

Consultant

Claus Bachert, MD, PhD

Sanofi

Consultant

Glaxo Smith Kline

Consultant

Novartis

Consultant

AstraZeneca

Consultant

Allakos

Consultant

Fuad M. Baroody, MD

Allergan

Consultant

Glaxo Smith Kline

Consultant

MEDA

Speaker

G. Walter Canonica, MD

A. Menarini

Research or speaker or advisory

ALK-Abello

Research or speaker or advisory

Anallergo

Research or speaker or advisory

AstraZeneca

Research or speaker or advisory

Boehringer Ingelheim

Research or speaker or advisory

Chiesi Farmaceutici

Research or speaker or advisory

Circassia

Research or speaker or advisory

Genentech

Research or speaker or advisory

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.